Sino Biopharmaceutical (1177.HK) - EPS (earnings per share)

EPS in 2021 (TTM): C$0.04663

According to Sino Biopharmaceutical's latest financial reports the company's current EPS (TTM) is C$0.04887. In 2024 the company made an earnings per share (EPS) of C$0.03586 an increase over its 2023 EPS that were of C$0.02436.

EPS history for Sino Biopharmaceutical from 1999 to 2021

Annual EPS

Year	EPS	Change
2024	C$0.03586	47.17%
2023	C$0.02436	-9.68%
2022	C$0.02697	-83.86%
2021	C$0.17	440.46%
2020	C$0.03091	7.54%
2019	C$0.02875	-70.37%
2018	C$0.09701	254.37%
2017	C$0.02738	41.55%
2016	C$0.01934	2.59%
2015	C$0.01885	17.63%
2014	C$0.01603	45.97%
2013	C$0.01098	16.34%
2012	C$0.009437	93.4%
2011	C$0.004880	-20.02%
2010	C$0.006101	33.16%
2009	C$0.004582	774.72%
2008	C$0.0005238	-79.69%
2007	C$0.002579	58.8%
2006	C$0.001624	-91.05%
2005	C$0.01814	723.97%
2004	C$0.002202	105.48%
2003	C$0.001072	-67.27%
2002	C$0.003274	-8.26%
2001	C$0.003569	17.18%
2000	C$0.003045	-1.9%
1999	C$0.003104

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

EPS for Sino Biopharmaceutical (1177.HK)